What is BPC-157 + TB-500 used for?

BPC-157 + TB-500 is studied for injury recovery, tendon & ligament repair, and joint support. Each peptide has animal evidence for healing. The combination itself has not been tested in controlled human trials.

What is the typical BPC-157 + TB-500 dosage?

Published protocols describe 0.5–2.5 mg total per dose, given subcutaneous. This is context from the literature, not a recommendation: a licensed provider sets the dose.

What are the side effects of BPC-157 + TB-500?

Risks noted for BPC-157 + TB-500 include injection-site reactions and limited human trial data. Tell your provider about your medications and conditions before starting.

How long do the peptides in BPC-157 + TB-500 last in the body?

The reported half-life is minutes to hours (by component). Onset is typically reported at 1–3 weeks.

How should BPC-157 + TB-500 be stored?

Refrigerated (2–8 °C); use within the pharmacy beyond-use date.

HEALING · PEPTIDE BLEND

What is BPC-157 + TB-500?

Medically reviewed by the G1 Peptides clinical team · Updated October 1, 2026

THE SHORT ANSWER

A BPC-157 and TB-500 blend combines two peptides studied for tissue repair in a single preparation. BPC-157 is studied for blood-vessel growth and gut and tendon healing, and TB-500 for cell migration and soft-tissue recovery.

BPC-157 + TB-500 at a glance

Type: Peptide blend
Also known as: Wolverine stack, BPC/TB blend
Mechanism: BPC-157 (angiogenic signalling) + TB-500 (cell migration)
Status: Compounded (Rx)
Half-life: Minutes to hours (by component)
Route: Subcutaneous
Dosing range in the literature: 0.5–2.5 mg total per dose
Onset: 1–3 weeks
Storage: Refrigerated (2–8 °C); use within the pharmacy beyond-use date

How BPC-157 + TB-500 works

The two act through different pathways: BPC-157 on growth-factor and nitric oxide signalling, TB-500 on actin and cell movement. They are combined on the theory that the effects are complementary, with one injection instead of two.

What BPC-157 + TB-500 is studied for

Injury recovery
Tendon & ligament repair
Joint support

Each peptide has animal evidence for healing. The combination itself has not been tested in controlled human trials.

Being studied for something is not proof that it works. Results in individuals vary.

BPC-157 + TB-500 dosing

Published protocols describe 0.5–2.5 mg total per dose, daily to twice weekly, given subcutaneous. Onset is typically reported at 1–3 weeks.

These figures are context from the literature, not instructions. A licensed provider sets the dose and schedule for each patient.

BPC-157 + TB-500 dosage calculator →

BPC-157 + TB-500 side effects and risks

Injection-site reactions
Limited human trial data

Tell your provider about every medication and condition before starting, and report anything unexpected. See peptide side effects and safety and who should not use peptides.

Is BPC-157 + TB-500 FDA approved?

Neither component is FDA-approved. Both are prohibited in sport by the World Anti-Doping Agency.

Approval and trial status change. This page was last reviewed on October 1, 2026.

BPC-157 + TB-500 at G1 Peptides

G1 Peptides supplies BPC-157 + TB-500 as vials (Blend vials) and in pens (Wolverine, Wolverine-S, GLOW, KLOW, X-23). Prescription products ship only after a licensed provider has reviewed the order.

Shop BPC-157 + TB-500 →

BPC-157 + TB-500 questions

What is BPC-157 + TB-500?: A BPC-157 and TB-500 blend combines two peptides studied for tissue repair in a single preparation. BPC-157 is studied for blood-vessel growth and gut and tendon healing, and TB-500 for cell migration and soft-tissue recovery.
What is BPC-157 + TB-500 used for?: BPC-157 + TB-500 is studied for injury recovery, tendon & ligament repair, and joint support. Each peptide has animal evidence for healing. The combination itself has not been tested in controlled human trials.
How does BPC-157 + TB-500 work?: The two act through different pathways: BPC-157 on growth-factor and nitric oxide signalling, TB-500 on actin and cell movement. They are combined on the theory that the effects are complementary, with one injection instead of two.
Is BPC-157 + TB-500 FDA approved?: Neither component is FDA-approved. Both are prohibited in sport by the World Anti-Doping Agency.
What is the typical BPC-157 + TB-500 dosage?: Published protocols describe 0.5–2.5 mg total per dose, given subcutaneous. This is context from the literature, not a recommendation: a licensed provider sets the dose.
What are the side effects of BPC-157 + TB-500?: Risks noted for BPC-157 + TB-500 include injection-site reactions and limited human trial data. Tell your provider about your medications and conditions before starting.
How long do the peptides in BPC-157 + TB-500 last in the body?: The reported half-life is minutes to hours (by component). Onset is typically reported at 1–3 weeks.
How should BPC-157 + TB-500 be stored?: Refrigerated (2–8 °C); use within the pharmacy beyond-use date.

For educational purposes only, and not medical advice. These statements have not been evaluated by the FDA. Nothing on this page is intended to diagnose, treat, cure, or prevent any disease. Use any compound only under the guidance of a licensed provider.